66358-50-7 Usage
Uses
Used in Pharmaceutical Industry:
(6aS,12aR)-2,3-dimethoxy-6-methyl-6a,12a-dihydro-5H-[1,3]dioxolo[5,6]indeno[1,2-c]isoquinoline-5,12(6H)-dione is used as a potential pharmaceutical candidate for [specific application reason] due to its complex and biologically active structure.
Used in Chemical Research:
(6aS,12aR)-2,3-dimethoxy-6-methyl-6a,12a-dihydro-5H-[1,3]dioxolo[5,6]indeno[1,2-c]isoquinoline-5,12(6H)-dione is used as a subject of chemical research for [specific research purpose], such as exploring its synthesis, properties, or potential applications in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 66358-50-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,3,5 and 8 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 66358-50:
(7*6)+(6*6)+(5*3)+(4*5)+(3*8)+(2*5)+(1*0)=147
147 % 10 = 7
So 66358-50-7 is a valid CAS Registry Number.
66358-50-7Relevant academic research and scientific papers
Synthesis and biological activity of structural analogues of the anticancer benzophenanthridine alkaloid nitidine chloride
Cushman,Mohan,Smith
, p. 544 - 547 (2007/10/02)
The indenoisoquinoline analogue 9 of nitidine (1) has been prepared and found to possess significant anticancer activity against L1210 lymphoid leukemia, P388 lymphocytic leukemia, and B16 melanocarcinoma. Analogue 14, which lacks the B ring of nitidine (1), has also been synthesized. Compound 14 retains the in vitro toxicity associated with nitidine (1) but is devoid of antileukemic activity. The structural factors that may contribute to the difference in biological activity between the two closely related analogues 9 and 14 are discussed.
